RBC Capital Markets Downgrades Schott Pharma to Sector Perform, Boosts PT

MT Newswires · 11/05 08:40
08:40 AM EST, 11/05/2026 (MT Newswires) -- RBC Capital Markets on Thursday downgraded German drug containment and delivery systems company Schott Pharma (1SXP.F) to sector perform from outperform and raised its price target to 25 euros from 21 euros. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)